ID   LaNCE hiPSC-28
AC   CVCL_WR81
SY   hiPSC-28; iPS-28; hiPS 28; iPS-HT4; iPS 28 - HT4; LANCEi029-A
DR   hPSCreg; LANCEi029-A
DR   Wikidata; Q95981235
RX   PubMed=29433076;
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 20
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=29433076; DOI=10.1016/j.scr.2018.01.030;
RA   Sarafian R.D., Morato-Marques M., Borsoi J., Pereira L.V.;
RT   "Monitoring cell line identity in collections of human induced
RT   pluripotent stem cells.";
RL   Stem Cell Res. 28:66-70(2018).
//
RX   PubMed=34088012; DOI=10.1016/j.scr.2021.102384;
RA   Sarafian R.D., Morato-Marques M., Borsoi J., Tofoli de Araujo F.,
RA   Pinheiro M., Medina-Armenteros Y., Lotufo P.A., Bensenor I.J.M.,
RA   Pereira L.V.;
RT   "Generation of 6 lines of human pluripotent stem cells from
RT   hypertensive patients and 3 lines of human pluripotent stem cell from
RT   normotensive patients.";
RL   Stem Cell Res. 53:102384-102384(2021).
//